Categories News Press Releases Archives 2025 January 2024 December November October September August July June May April March February January 2023 December November October September August July June May April March February January 2022 December November October September August July June May April March February January 2021 December November October September August July June May April March February January 2020 December November October September August July June May April March February January 2019 December November October September August July June May April March February January 2018 December November October September August July June May April March February January Jan 16 UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx) Read More Share:| |